§ Mr. Simon BurnsTo ask the Secretary of State for Health (1) if he will make a statement on the criteria for the use of Tamoxifen; [46720] (2) what plans he has for the use of Tamoxifen for women who do not have breast cancer but are considered to be at high risk. [46721]
§ Yvette CooperTamoxifen is licensed for the treatment of breast cancer and the treatment of anovulatory infertility.
1448WTamoxifen is not licensed for the prevention of breast cancer in women who do not have breast cancer. A large international research trial is currently investigating whether Tamoxifen can prevent cancer in healthy women who are considered to be at high risk. When the full trial results are published we will consider what action may be appropriate and estimate the cost implications.